223 related articles for article (PubMed ID: 11415457)
1. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.
Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM
Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457
[TBL] [Abstract][Full Text] [Related]
2. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
4. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
Achkar C; Gong QM; Frankfater A; Bajkowski AS
J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
[TBL] [Abstract][Full Text] [Related]
5. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
7. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
8. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line.
De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C
Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605
[TBL] [Abstract][Full Text] [Related]
9. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress.
Kågedal K; Johansson U; Ollinger K
FASEB J; 2001 Jul; 15(9):1592-4. PubMed ID: 11427496
[No Abstract] [Full Text] [Related]
10. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
11. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.
Taillandier D; Aurousseau E; Meynial-Denis D; Bechet D; Ferrara M; Cottin P; Ducastaing A; Bigard X; Guezennec CY; Schmid HP
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):65-72. PubMed ID: 8645234
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.
Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG
Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556
[TBL] [Abstract][Full Text] [Related]
13. [Expression of cathepsins D and L during neoplastic transformation of fibroblasts].
Dilakian EA; Balaevskaia TO; Zakamaldina-Tsama TA; Topol' LZ; Solov'eva NI
Vopr Med Khim; 1994; 40(3):2-6. PubMed ID: 8079433
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
[TBL] [Abstract][Full Text] [Related]
15. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
16. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.
Yamada H; Nishimura F; Naruishi K; Chou HH; Takashiba S; Albright GM; Nares S; Iacopino AM; Murayama Y
J Periodontol; 2000 Jun; 71(6):955-60. PubMed ID: 10914799
[TBL] [Abstract][Full Text] [Related]
17. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC).
Lah TT; Calaf G; Kalman E; Shinde BG; Russo J; Jarosz D; Zabrecky J; Somers R; Daskal I
Biol Chem Hoppe Seyler; 1995 Jun; 376(6):357-63. PubMed ID: 7576229
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
20. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells.
Hiwasa T; Kominami E
Biochem Biophys Res Commun; 1995 Nov; 216(3):828-34. PubMed ID: 7488200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
